Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rigel Pharmaceuticals
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A history of dry eye (based on the date of initial dry eye symptoms)
Use of over-the-counter (OTC) and/or prescription eye drops for dry eye symptoms
Corneal fluorescein staining score of at least 2 in the inferior region
You may not be if
History of, or a concurrent clinically significant illness, medical condition (other than Keratoconjunctivitis Sicca or Sjögren's syndrome), or laboratory abnormality that, in the Investigator's opinion, could affect the conduct of the study.
Use of ophthalmic cyclosporine within 45 days of Visit 1.
Use of any topical ophthalmic steroid within 2 weeks of Visit 1.
Have worn contact lenses or anticipate using contact lenses during the study.
Have a condition or be in a situation that the Investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Have a history of alcohol or substance abuse that, in the judgment of the Investigator, may impair or risk the subject's full participation in the study.
Clareo Health | To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
